低剂量纳尔特雷克松治疗慢性疼痛的有效性和安全性
Madison N Irwin1,2, David A Cooke3, Daniel Berland3
1Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
Journal of pain & palliative care pharmacotherapy
|February 1, 2024
概括
低剂量纳尔特雷 (LDN) 显示,慢性疼痛得分在统计学上显著降低. 然而,由于缺乏益处,大多数患者停止了LDN治疗,质疑其对疼痛管理的临床意义.
科学领域:
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 纳尔特雷克松是一种片受体对抗剂.
- 低剂量纳尔特雷 (LDN) 越来越多地用于慢性疼痛管理.
- 在常规临床实践中LDN的有效性需要评估.
研究的目的:
- 为了评估低剂量纳尔特雷 (LDN) 在患有慢性疼痛的成年人中的疗效.
- 描述LDN在门诊疼痛诊所环境中的临床使用和结果.
主要方法:
- 追溯性,观察性队列研究.
- 包括接受LDN (<10毫克) ≥1个月的成年人.
- 主要结局:疼痛,生活快乐和一般活动 (PEG) 评分的变化.
主要成果:
- 平均PEG得分从7.27下降到6.62 (p=0.022). 这是一个很大的变化.
- 87%的患者停止了LDN治疗,52%的患者表示缺乏益处.
- 7%的人报告了副作用.
结论:
- 在慢性疼痛患者中,LDN表明PEG得分在统计学上显著降低.
- 由于缺乏益处的高停药率,LDN的临床意义尚不确定.
相关概念视频
Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300
Opioid Analgesics: Morphine and Other Natural Cogeners
250
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
250
Nociception
27.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.9K
CNS Depressants: Alcohol and Nicotine
209
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
209
Drugs for Treatment of Diarrhea-Predominant IBS
175
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175


